Table 1 Demographic data and core AD biomarker levels for the clinical study^a

Number (Women/Men)

26 (17/9)

18 (13/5)

23 (17/6)

Age (years)

62 (53–69), P = 0.007^c

70 (69–78), P = 0.007^b

68 (64–72)

MMSE

27 (25–28)

27 (26–28)

22 (16–24), P < 0.00001^b, P = 0.00002^c

Aβ_1–42 (ng/L)

970 (811–1091), P = 0.00002^c

558 (377–667), P < 0.00002^b

496 (459–568), P < 0.00001^b

T-tau (ng/L)

182 (154–207), P < 0.00001^c

570 (520–717), P < 0.00001^b

618 (527–734), P < 0.00001^b

P-tau (ng/L)

35 (30–41), P < 0.00001^c

86 (79–104), P < 0.00001^b

90 (73–108), P < 0.00001^b